Objective: Diabetic retinopathy is one of the leading causes of blindness. We estimated the prevalence of diabetic retinopathy among a diabetic population in the Dubrovnik-Neretva County in the Republic of Croatia and searched for potential risk factors.
INTRODUCTION
Diabetes mellitus (DM) constitutes a major health problem for all age groups in many countries, affecting about 180 million people worldwide (1) . As a result of population growth, ageing, obesity and inactive lifestyle, it is estimated that the total number of people with diabetes will rise, particularly in developing countries, resulting in 300 million cases by the year 2025 (2) . The growing number of diabetic patients will inevitably lead to an increased prevalence of macrovascular and microvascular diabetic complications including diabetic retinopathy (DR).
DR is a common and progressive microvascular complication of diabetes and despite the availability of effective treatment it remains one of the leading causes of vision impairment and blindness in working-age adults (3) . It affects three-quarters of individuals who have had diabetes mellitus for more than 15 years (1) . According to the Wisconsin epidemiologic study of diabetic retinopathy (WESDR), 3.6% of patients with type 1 and 1.6% of patients with type 2 diabetes were considered legally blind; 86% of legal blindness in type 1, and 33% in type 2 diabetic patients was attributable to DR (4) .
Retinopathy may lead to increased morbidity, disability and even mortality and therefore represents a major health problem in patients with diabetes. Since this unavoidably puts a great burden on healthcare system, diminishing the influence of this complication becomes highly desirable.
Despite the gravity of potential risks of diabetic complications, to our best knowledge, no study has been undertaken to estimate the impact of this problem in the Republic of Croatia. Our study aims to report the prevalence of diabetic retinopathy, its types, and patient characteristics in a diabetic population in the Dubrovnik-Neretva County, the southernmost region of the Republic of Croatia. Identification of potential risk factors and particularly high-risk groups becomes important for the assessment and amendment of strategies and planning of public health policies on the prevention and treatment of diabetic retinopathy.
MATERIALS AND METHODS

Patients
The Dubrovnik-Neretva County in the Republic of Croatia is located on the Adriatic coast. It encompasses an area of 1,785 km 2 and has 122,879 residents. Territorially, it is organized into 22 local self-administration units, divided into 5 cities, and 17 municipalities. The centre of County is the City of Dubrovnik.
This study included 600 patients with diabetes from different parts of the county who attended regular medical and ophthalmological check-ups in Dubrovnik General Hospital from September 2014 to September 2015. The sample group in this study is estimated to represent 20% of the known total diabetic population in the County.
Data Collection Procedures
All patients underwent a standardized interview, medical examination (including collection of blood samples) and a thorough eye examination.
A full medical history was taken from each patient including age at time of examination, age at time of diabetes diagnosis (first recorded by a physician), duration of diabetes (time between age at diagnosis and age at time of examination), family history, type of diabetes (based on the World Health Organization (WHO) classification) (5), smoking status, alcohol intake, and medication. Additionally, a history of chronic disease including hypertension, ischaemic heart disease, cerebral stroke, terminal renal disease, and glaucoma was recorded. The diabetic treatment status was recorded as diet only, oral hypoglycaemics or insulin treatment. Patients on both oral hypoglycaemics and insulin were categorized as insulin dependent. Blood pressure was measured early in the morning in a sitting position in both arms using a standard mercury sphygmomanometer. Hypertension was defined as the presence of systolic blood pressure (SBP) > 140 mmHg and diastolic blood pressure (DBP) > 90 mmHg or use of antihypertensive medications. Height was measured without shoes and weight recorded while wearing indoor clothing. Using the height and weight measurement results, body mass index (BMI) was calculated (weight in kilograms, divided by height in meters squared). The WHO classification for BMI was used to estimate the degree of weight excess (5) being defined minimally as a BMI ≥ 25 kg/m 2 . Fasting venous blood samples were collected and sent for analysis of serum lipid levels including total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides, glycated haemoglobin (HbA 1 c), glucose and creatinine at the laboratory at Dubrovnik General Hospital. HbA 1 c less than 7% was considered to indicate good glycaemic control. Hypercholesterolemia was defined as total cholesterol level of ≥ 6.2 mmol/l or use of lipidlowering drugs. Dyslipidaemia was taken to be present when total cholesterol was > 5.6 mmol/l and/or triglycerides > 2.10 mmol/l, LDL > 3.4 mmol/l, and/or HDL < 0.91 mmol/l (5).
Diagnosis of Diabetic Retinopathy
Ophthalmologic assessments were performed by two ophthalmologists (experienced retinal specialist) and included measurement of visual acuity with Snellen chart, applanation tonometry with the Goldman tonometer, slit lamp biomicroscopy of the anterior eye segment and ophthalmoscopy. After pupil dilatation with topical 1% tropicamide detailed fundus examination for presence of diabetic retinopathy was performed using a Volk TransEquator lens. Assessment was carried out on seven fields and the diagnosis and pathological retinal findings were carefully recorded. In all the patients in whom diabetic retinopathy was established, fluorescein angiography was conducted. Any retinopathy presented in this study was classified as mild non-proliferative diabetic retinopathy (NPDR), moderate-severe NPDR and proliferative diabetic retinopathy (PDR) according to the summed interpretation of fluorescein angiography and the recorded ophthalmoscopic grading, using a scale modified from the Airlie House grading system (6) . The severity of retinopathy was determined according to the grading of the seriously affected eye. Legal blindness was defined as best corrected visual acuity of 0.1 (6/60) or less in the better eye.
Statistical Analysis
Descriptive and inferential statistics were used for data analysis. Mean and ± standard deviation, and percentages were used as descriptive parameters of quantitative variables, y significant. Differences in distributions of categorical data were evaluated by Chi-square test and comparison of means by T test. Statistical significance was set at the 0.05 probability level. All statistical analyses were performed with the SPSS 13.0 software (SPSS Inc., Chicago, IL, USA).
RESULTS
We screened 600 patients with diabetes, the majority (90.83%) had DM type 2.
The mean age was 65.37 years overall, 38.9 years for DM type 1 in men, 33.9 years for DM type 1 in women; 66.41 years for DM type 2 in men, and 70.25 years for DM type 2 in women. The mean duration of diabetes diagnosis was 12.94 years overall, 12.89 years in men and 12.94 in women.
The prevalence of DR in patients with diabetes in our sample was 44.5%, 20.7% had the mild form, 18.8% had the moderatesevere form and 5.0% had PDR; 168 (28%) patients were treated by laser and 22 (3.7%) by vitrectomy.
Concerning the risk factors hypercholesterolemia was present in 16% of participants, hypertriglyceridemia in 9.67%, and glaucoma in 12.17%, while 26 (4.44%) of patients were legally blind. The overall mean BMI was 27.14; in diabetics without DR 26.19, in diabetics with mild DR 28.06, in those with the moderate-severe form 28.49, and in those with PDR 28.79. All characteristics of the patients can be seen in Table 1 .
No consistent association between gender and DR prevalence in persons with diabetes was observed (p = 0.399). While the duration of diabetes, raised BMI and elevated cholesterol level were significantly associated with an increased risk of DR. Conversely, hypertension and elevated triglycerides levels were not significantly associated with an increased risk of DR (Table 2) . 55 patients with DM type 1 were qualified for the study, 18 of them had retinopathy, while among 545 patients with DM type 2 249 patients had diabetic retinopathy diagnosed. The association between the duration of diabetes and level of retinopathy is presented in Table 3 . 
DISCUSSION
Recent studies show an increasing prevalence of diabetes and DR across the globe (3, 7, 8) . To our best knowledge this is the first attempt to estimate the prevalence rates of DR among diabetic patients in the Dubrovnik-Neretva County in the Republic of Croatia. Our purpose was to quantify the degree of DR problem in patients with diabetes in our county and reveal which patient characteristics can be seen as potential risk factors for the development of DR, particularly those changeable.
Our results show that an increased duration of diabetes, poorly controlled cholesterol level and raised BMI are characteristics associated with an increased risk of DR. Across the globe, in various population groups, a great number of studies have been Cholesterol (mmol/l) 4.6 (0.9) 5.0 (1.0) < 0.001
Triglycerides (mmol/l) 1.5 (0.9) 1.5 (0.5) 0.370 performed looking at potential risk factors for the development of DR. A number of studies have found, like us, that a longer duration of diabetes, poorly controlled HbA 1 c and raised BMI are associated with an increased risk of DR (9) (10) (11) (12) (13) (14) (15) . In contrast to our results many studies have also found high blood pressure, poor glycaemic control and proteinuria to be risk factors for the development of DR (16) (17) (18) (19) (20) . Such information is necessary in order to facilitate timely intervention, development of preventative procedures, and for the planning of future screening services for DR. Additionally, the presence of DR could also be considered an indicator of microcirculatory dysfunction in other vital organs in the body as well as in the eye (21) . Some studies suggest that the presence of DR may be linked to an increased risk of systemic vascular complications, such as coronary heart disease, stroke and nephropathy (22) (23) (24) (25) (26) . Therefore, an increase in awareness of DR and its risk factors will enable better comprehension of systemic diabetic complications.
Visual impairment as a result of DR has a significant impact on the quality of life of affected patients (27, 28) and can compromise their ability to successfully manage their disease, which can in turn have a negative impact on the incidence of other diabetic complications and even overall life expectancy of patients (29) . Consequently, early detection and management of DR in patients with diabetes is essential in preserving quality of life for affected individuals.
CONCLUSION
Our results show, for the first time, the prevalence rates of DR for the Dubrovnik-Neretva County in the Republic of Croatia. The incidence and prevalence of diabetes mellitus in our County follow and even exceeded rates reported in the developed countries whilst at the same time facilities for the detection and treatment of DR remain limited. The results of this study serve to highlight the need for a greater orientation of healthcare services to the earlier detection of DR. Our findings pertaining to the duration of diabetes poorly controlled HbA 1 c and raised BMI as risk factors for the development of DR further emphasize the need of screening and early detection of DR particularly in the most susceptible patient group.
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